FISM: harnessing deep learning and reinforcement learning for precision detection of microaneurysms and retinal exudates for early diabetic retinopathy diagnosis.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: The source evaluates lesion segmentation/classification with accuracy, precision, recall, IoU and ROC analyses.
Technology: FISM combines deep-learning lesion segmentation and reinforcement-learning detection for diabetic-retinopathy lesions.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- FISM combines deep-learning lesion segmentation and reinforcement-learning detection for diabetic-retinopathy lesions.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/41168809 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12576988/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.